Latest Content From Ruairi J MacKenzie
Oxford Medistress, developer of the Leukocyte Coping Capacity (LCC) test, says that the test can measure your stress levels in 10 minutes, by sampling a drop of your blood. Could the test revolutionize the field of stress diagnostics? In this article we explore the history of measuring stress, and find out whether the LCC will be a milestone or side-note in that history.VIEW
Predicting the future isn’t straightforward, but efforts to move research forward are happening in the here and now, and we can look to technologies in their infancy today that promise to become essential parts of research practice tomorrow. This infographic will investigate some of these technologies and the impact they could have on research.
Cryogenic electron microscopy (cryo-EM) is an indispensable technique for structural biologists. But this wasn’t always the case. We spoke to Bridget Carragher, Co-Director of the Simons Electron Microscopy Center to discover how automation has improved cryo-EM.VIEW
Hovione, a global contract development and manufacturing organization, has adopted method lifecycle management techniques (MLCM) for its chromatographic and detection. We sat down with Hovione’s Principal Analytical Chemist of Analytical Development, Antonio Ramos and Waters Corporation’s Principal Consulting Scientist Dr Paula Hong to discuss MLCM.
Over 100 years has passed since Alois Alzheimer’s pioneering work into recognizing the symptoms of dementia. This list will review the current techniques that are used to diagnose dementia and the advances that are being made to exploit some of Alzheimer’s original discoveries to more quickly and accurately assess dementia.
At the British Neuroscience Association's Festival of Neuroscience 2019, we pulled aside one of the BNA's credibility board, Dr Verena Heise to ask her about credibility in neuroscience, how she became involved in promoting it, and how other players in research can help advance the credibility cause.VIEW
We recently spoke to Charlie Silver, CEO and Co-Founder of Mission Bio, to learn more about how they are helping researchers profile mutational heterogeneity at the single-cell level.VIEW
A system capable of translating brain activity into synthesised speech by decoding the movements of muscles involved in vocalisation has shown its potential in a proof-of-concept experiment conducted by researchers at the University of California San Francisco.VIEW
A significant minority of major depressive disorder patients don’t respond to currently available antidepressant medication. A newly approved treatment, based on the "club drug" ketamine, could change that. In a session at the British Neuroscience Association’s Festival of Neuroscience 2019, the potential mechanisms of ketamine’s antidepressant action were put under examination.VIEW
Cloud technologies are becoming a central part of modern research. Nonetheless, questions about the security and shareability of cloud data remain. We caught up with Google Cloud’s Director of Google for Education NA Kevin Kells to discuss the projects that show how the cloud is changing research, and that new technologies are making secure and simple data sharing a reality.VIEW